Abstract
Mutation of the human immunodeficiency virus by host cells inhibits viral dissemination by creating nonfunctional variants. However, viral mutation does not always eliminate the ability of the virus to disseminate and, in fact, is thought to promote persistence by generating functional mutants that evade immunity or drugs. How and where HIV mutates is not known. Accordingly, where and to what extent variants emerge may be determined by the cell type with optimal mutation apparatus as well as by the properties of the viral genomic sequence itself. Here we considered that HIV, which can infect B cells, may co-opt the Ig somatic hypermutation machinery to generate functional variants and asked whether the HIV envelope coding sequence can diversify in B cells. We show that an HIV envelope coding sequence transfected into B cells mutates in a manner consistent with somatic hypermutation, causing the production of viral protein variants. This result demonstrates that B cells can express and diversify HIV proteins. Thus, B cells may contribute to viral evasion and to the development of multi-drug resistance.
Keywords: B cells, HIV, quasi-species
Current HIV Research
Title: HIV Genes Diversify in B Cells
Volume: 6 Issue: 1
Author(s): Marilia Cascalho, Samuel J. Balin, Ted M. Ross and Jeffrey L. Platt
Affiliation:
Keywords: B cells, HIV, quasi-species
Abstract: Mutation of the human immunodeficiency virus by host cells inhibits viral dissemination by creating nonfunctional variants. However, viral mutation does not always eliminate the ability of the virus to disseminate and, in fact, is thought to promote persistence by generating functional mutants that evade immunity or drugs. How and where HIV mutates is not known. Accordingly, where and to what extent variants emerge may be determined by the cell type with optimal mutation apparatus as well as by the properties of the viral genomic sequence itself. Here we considered that HIV, which can infect B cells, may co-opt the Ig somatic hypermutation machinery to generate functional variants and asked whether the HIV envelope coding sequence can diversify in B cells. We show that an HIV envelope coding sequence transfected into B cells mutates in a manner consistent with somatic hypermutation, causing the production of viral protein variants. This result demonstrates that B cells can express and diversify HIV proteins. Thus, B cells may contribute to viral evasion and to the development of multi-drug resistance.
Export Options
About this article
Cite this article as:
Cascalho Marilia, Balin J. Samuel, Ross M. Ted and Platt L. Jeffrey, HIV Genes Diversify in B Cells, Current HIV Research 2008; 6 (1) . https://dx.doi.org/10.2174/157016208783571919
DOI https://dx.doi.org/10.2174/157016208783571919 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress
Current Medicinal Chemistry Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Current Drug Targets Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Flavonoids Protect Cerebrovascular Endothelial Cells through Nrf2 and PI3K from β-Amyloid Peptide-Induced Oxidative Damage
Current Neurovascular Research Early Functional and Structural Microvascular Changes in Hypertension Related to Aging
Current Hypertension Reviews Oral Administration of the Food-Derived Hydrophilic Antioxidant Ergothioneine Enhances Object Recognition Memory in Mice
Current Molecular Pharmacology Endothelial Dysfunction in Renal Failure: Current Update
Current Medicinal Chemistry The Glutathione System and its Regulation by Neurohormone Melatonin in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression
Current Medicinal Chemistry Sestrins: A New Kid for Stroke Treatment?
Current Drug Delivery Decline of Executive Processes Affects the Identification of Emotional Facial Expressions in Aging
Current Aging Science S100A9 Exacerbates the Aβ1-42-mediated Innate Immunity in Human THP-1 Monocytes
CNS & Neurological Disorders - Drug Targets Structural MRI Predictors of Late-Life Cognition Differ Across African Americans, Hispanics, and Whites
Current Alzheimer Research Genomic and Molecular Characterization of Alzheimer Disease
Current Psychiatry Reviews A New “Era” for the α7-nAChR
Current Drug Targets Prematurely Aged Children: Molecular Alterations Leading to Hutchinson-Gilford Progeria and Werner Syndromes
Current Aging Science Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets